Wolfgang Miesbach

5.7k total citations
192 papers, 3.2k citations indexed

About

Wolfgang Miesbach is a scholar working on Hematology, Genetics and Genetics. According to data from OpenAlex, Wolfgang Miesbach has authored 192 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Hematology, 39 papers in Genetics and 36 papers in Genetics. Recurrent topics in Wolfgang Miesbach's work include Hemophilia Treatment and Research (98 papers), Platelet Disorders and Treatments (58 papers) and Virus-based gene therapy research (31 papers). Wolfgang Miesbach is often cited by papers focused on Hemophilia Treatment and Research (98 papers), Platelet Disorders and Treatments (58 papers) and Virus-based gene therapy research (31 papers). Wolfgang Miesbach collaborates with scholars based in Germany, United States and Italy. Wolfgang Miesbach's co-authors include Michael Makris, Frank W.G. Leebeek, Sonja Alesci, Robert Klamroth, Erhard Seifried, I. Scharrer, Edelgard Lindhoff‐Last, Giancarlo Castaman, E. Seifried and Johannes Oldenburg and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Wolfgang Miesbach

168 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wolfgang Miesbach Germany 27 1.7k 596 567 511 371 192 3.2k
Dolors Tàssies Spain 30 842 0.5× 332 0.6× 256 0.5× 295 0.6× 284 0.8× 117 3.0k
Rob Fijnheer Netherlands 40 1.6k 1.0× 201 0.3× 361 0.6× 267 0.5× 590 1.6× 137 4.4k
Abdulgabar Salama Germany 32 2.4k 1.4× 500 0.8× 341 0.6× 363 0.7× 770 2.1× 141 4.4k
Kathelijne Peerlinck Belgium 32 2.5k 1.5× 201 0.3× 459 0.8× 155 0.3× 579 1.6× 133 3.5k
Guillermo J. Ruíz‐Argüelles Mexico 30 2.1k 1.2× 108 0.2× 450 0.8× 521 1.0× 599 1.6× 307 3.2k
J. Mark Sloan United States 27 510 0.3× 175 0.3× 1.0k 1.8× 529 1.0× 522 1.4× 143 2.4k
Pratima Chowdary United Kingdom 31 2.6k 1.6× 298 0.5× 498 0.9× 320 0.6× 703 1.9× 161 3.7k
Sabrina Gavasso Italy 30 1.4k 0.8× 221 0.4× 354 0.6× 182 0.4× 333 0.9× 70 2.5k
Paul Knöbl Austria 42 3.2k 1.9× 158 0.3× 678 1.2× 359 0.7× 1.2k 3.2× 159 5.6k
Wael Saber United States 31 2.7k 1.6× 164 0.3× 409 0.7× 869 1.7× 612 1.6× 173 3.7k

Countries citing papers authored by Wolfgang Miesbach

Since Specialization
Citations

This map shows the geographic impact of Wolfgang Miesbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Miesbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Miesbach more than expected).

Fields of papers citing papers by Wolfgang Miesbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Miesbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Miesbach. The network helps show where Wolfgang Miesbach may publish in the future.

Co-authorship network of co-authors of Wolfgang Miesbach

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Miesbach. A scholar is included among the top collaborators of Wolfgang Miesbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Miesbach. Wolfgang Miesbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hermans, Cédric, Carmen Unzu, Mark A. Kay, et al.. (2025). Operationalising a Haemophilia Gene Editing Lexicon for Practical Use. Haemophilia. 31(2). 207–213.
2.
Glasner, Margaret E., Steven W. Pipe, & Wolfgang Miesbach. (2025). Gene-based therapies for hemophilia. Research and Practice in Thrombosis and Haemostasis. 9(4). 102870–102870.
3.
Dobbelstein, Christiane, Robert Klamroth, Christina Hart, et al.. (2025). Sustained survival benefit of emicizumab and postponed immunosuppression in acquired hemophilia A. Blood Advances. 9(22). 5853–5860.
4.
Pipe, Steven W., Wolfgang Miesbach, Michael Recht, et al.. (2025). Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B. New England Journal of Medicine. 394(5). 463–474.
5.
Roth, Susanne, et al.. (2025). Prognostic factors for recurrence in acquired hemophilia A-results from a long-term observational study. Research and Practice in Thrombosis and Haemostasis. 9(2). 102707–102707.
6.
Miesbach, Wolfgang, Barbara A. Konkle, Pratima Chowdary, et al.. (2024). Recommendations for a minimum data set for monitoring gene therapy in hemophilia: communication from the ISTH SSC Working Group on Gene Therapy. Journal of Thrombosis and Haemostasis. 22(5). 1510–1515. 5 indexed citations
7.
Agarwal, Suresh, Cédric Hermans, Wolfgang Miesbach, et al.. (2024). Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia A. Haemophilia. 30(4). 905–913.
8.
Minno, Giovanni Di, Wolfgang Miesbach, Giancarlo Castaman, & Flora Peyvandi. (2024). Next-generation strategies to improve safety and efficacy of adeno-associated virus-based gene therapy for hemophilia: lessons from clinical trials in other gene therapies. Haematologica. 109(12). 3879–3891. 4 indexed citations
9.
Hermans, Cédric, Leonard A. Valentino, Courtney D. Thornburg, et al.. (2024). A novel gene editing lexicon strategy for the haemophilia community: Research plan for development and preliminary results. Haemophilia. 30(6). 1272–1280. 2 indexed citations
10.
Sachs, Ulrich J., Karolin Trautmann‐Grill, Christian Pfrepper, et al.. (2024). Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study. Research and Practice in Thrombosis and Haemostasis. 8(7). 102565–102565.
11.
Dunn, Amy L., Yesim Dargaud, Manuel Carção, et al.. (2024). Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors. Haemophilia. 31(1). 78–86. 1 indexed citations
12.
Pfrepper, Christian, Robert Klamroth, Johannes Oldenburg, et al.. (2023). Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group. Hämostaseologie. 44(6). 466–471. 10 indexed citations
13.
Bullinger, Monika, Hannah B Lewis, Wolfgang Miesbach, et al.. (2021). The potential impact of gene therapy on health-related quality of life (HRQoL) domains in haemophilia. SHILAP Revista de lepidopterología. 8(1). 56–68. 4 indexed citations
14.
Miesbach, Wolfgang & Eileen K. Sawyer. (2018). Practical Implications of Factor IX Gene Transfer for Individuals with Hemophilia B: A Clinical Perspective. PubMed. 29(2). 80–89. 11 indexed citations
15.
Holstein, Katharina, Paul Knöbl, Christiane Dobbelstein, et al.. (2017). Factor VIII Activity and Risk of Bleeding in Acquired Hemophilia a: Results from the Gth-AH 01/2010 Study. Blood. 130. 22–22. 2 indexed citations
16.
Weber, Christian, Klaus Friedrich, Rüdiger Gerlach, et al.. (2010). Role of thrombelastometry for the monitoring of factor XIII: A prospective observational study in neurosurgical patients@@@Prospektive Observationsstudie bei neurochirurgischen Patienten. Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt). 31(2). 111–117. 1 indexed citations
17.
Miesbach, Wolfgang, et al.. (2009). Age‐dependent increase of FVIII:C in mild haemophilia A. Haemophilia. 15(5). 1022–1026. 15 indexed citations
18.
Miesbach, Wolfgang. (2008). Malignancies and Catastrophic Anti-phospholipid Syndrome. Clinical Reviews in Allergy & Immunology. 36(2-3). 91–97. 5 indexed citations
19.
Miesbach, Wolfgang, Torsten Matthias, & I. Scharrer. (2005). Identification of Thrombin Antibodies in Patients with Antiphospholipid Syndrome. Annals of the New York Academy of Sciences. 1050(1). 250–256. 16 indexed citations
20.
Miesbach, Wolfgang, et al.. (2003). Massive Blutungsneigung bei zwei Patienten mit Faktor-V-Hemmkörper und Anti-Phospholipid-Antikörpern nach Ciprofloxacin-Einnahme. Medizinische Klinik. 98(6). 339–343. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dolors Tàssies Breakdown of academic impact, for papers by Rob Fijnheer Breakdown of academic impact, for papers by Abdulgabar Salama Breakdown of academic impact, for papers by Kathelijne Peerlinck Breakdown of academic impact, for papers by Guillermo J. Ruíz‐Argüelles Breakdown of academic impact, for papers by J. Mark Sloan Breakdown of academic impact, for papers by Pratima Chowdary Breakdown of academic impact, for papers by Sabrina Gavasso Breakdown of academic impact, for papers by Paul Knöbl Breakdown of academic impact, for papers by Wael Saber
Rankless by CCL
2026